1. Home
  2. EVOK vs GXAI Comparison

EVOK vs GXAI Comparison

Compare EVOK & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • GXAI
  • Stock Information
  • Founded
  • EVOK 2007
  • GXAI 2021
  • Country
  • EVOK United States
  • GXAI United States
  • Employees
  • EVOK N/A
  • GXAI N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • GXAI
  • Sector
  • EVOK Health Care
  • GXAI
  • Exchange
  • EVOK Nasdaq
  • GXAI Nasdaq
  • Market Cap
  • EVOK 7.0M
  • GXAI 7.5M
  • IPO Year
  • EVOK 2013
  • GXAI 2023
  • Fundamental
  • Price
  • EVOK $4.96
  • GXAI $2.38
  • Analyst Decision
  • EVOK
  • GXAI
  • Analyst Count
  • EVOK 0
  • GXAI 0
  • Target Price
  • EVOK N/A
  • GXAI N/A
  • AVG Volume (30 Days)
  • EVOK 38.4K
  • GXAI 18.1M
  • Earning Date
  • EVOK 11-07-2024
  • GXAI 11-14-2024
  • Dividend Yield
  • EVOK N/A
  • GXAI N/A
  • EPS Growth
  • EVOK N/A
  • GXAI N/A
  • EPS
  • EVOK N/A
  • GXAI N/A
  • Revenue
  • EVOK $8,617,036.00
  • GXAI $2,979.00
  • Revenue This Year
  • EVOK $97.35
  • GXAI N/A
  • Revenue Next Year
  • EVOK $99.52
  • GXAI N/A
  • P/E Ratio
  • EVOK N/A
  • GXAI N/A
  • Revenue Growth
  • EVOK 100.35
  • GXAI N/A
  • 52 Week Low
  • EVOK $3.54
  • GXAI $1.01
  • 52 Week High
  • EVOK $14.04
  • GXAI $19.20
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 54.79
  • GXAI 49.01
  • Support Level
  • EVOK $4.33
  • GXAI $2.25
  • Resistance Level
  • EVOK $5.75
  • GXAI $4.41
  • Average True Range (ATR)
  • EVOK 0.39
  • GXAI 1.22
  • MACD
  • EVOK 0.13
  • GXAI -0.11
  • Stochastic Oscillator
  • EVOK 54.34
  • GXAI 18.73

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About GXAI Gaxos.ai Inc.

Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.

Share on Social Networks: